BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 32182706)

  • 21. Neuropeptide Y Enhances Progerin Clearance and Ameliorates the Senescent Phenotype of Human Hutchinson-Gilford Progeria Syndrome Cells.
    Aveleira CA; Ferreira-Marques M; Cortes L; Valero J; Pereira D; Pereira de Almeida L; Cavadas C
    J Gerontol A Biol Sci Med Sci; 2020 May; 75(6):1073-1078. PubMed ID: 32012215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progerin reduces LAP2α-telomere association in Hutchinson-Gilford progeria.
    Chojnowski A; Ong PF; Wong ES; Lim JS; Mutalif RA; Navasankari R; Dutta B; Yang H; Liow YY; Sze SK; Boudier T; Wright GD; Colman A; Burke B; Stewart CL; Dreesen O
    Elife; 2015 Aug; 4():. PubMed ID: 26312502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progerin impairs vascular smooth muscle cell growth via the DNA damage response pathway.
    Kinoshita D; Nagasawa A; Shimizu I; Ito TK; Yoshida Y; Tsuchida M; Iwama A; Hayano T; Minamino T
    Oncotarget; 2017 May; 8(21):34045-34056. PubMed ID: 28423660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progressive vascular smooth muscle cell defects in a mouse model of Hutchinson-Gilford progeria syndrome.
    Varga R; Eriksson M; Erdos MR; Olive M; Harten I; Kolodgie F; Capell BC; Cheng J; Faddah D; Perkins S; Avallone H; San H; Qu X; Ganesh S; Gordon LB; Virmani R; Wight TN; Nabel EG; Collins FS
    Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3250-5. PubMed ID: 16492728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronary and carotid artery dysfunction and K
    Macías Á; Nevado RM; González-Gómez C; Gonzalo P; Andrés-Manzano MJ; Dorado B; Benedicto I; Andrés V
    Geroscience; 2024 Feb; 46(1):867-884. PubMed ID: 37233881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progerinin, an optimized progerin-lamin A binding inhibitor, ameliorates premature senescence phenotypes of Hutchinson-Gilford progeria syndrome.
    Kang SM; Yoon MH; Ahn J; Kim JE; Kim SY; Kang SY; Joo J; Park S; Cho JH; Woo TG; Oh AY; Chung KJ; An SY; Hwang TS; Lee SY; Kim JS; Ha NC; Song GY; Park BJ
    Commun Biol; 2021 Jan; 4(1):5. PubMed ID: 33398110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progerin induces a phenotypic switch in vascular smooth muscle cells and triggers replication stress and an aging-associated secretory signature.
    Coll-Bonfill N; Mahajan U; Shashkova EV; Lin CJ; Mecham RP; Gonzalo S
    Geroscience; 2023 Apr; 45(2):965-982. PubMed ID: 36482259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of vascular aging: What can we learn from Hutchinson-Gilford progeria syndrome?
    Del Campo L; Hamczyk MR; Andrés V; Martínez-González J; Rodríguez C;
    Clin Investig Arterioscler; 2018; 30(3):120-132. PubMed ID: 29602596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progerin in muscle leads to thermogenic and metabolic defects via impaired calcium homeostasis.
    Wang WP; Wang JY; Lin WH; Kao CH; Hung MC; Teng YC; Tsai TF; Chi YH
    Aging Cell; 2020 Feb; 19(2):e13090. PubMed ID: 31833196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysfunction of iPSC-derived endothelial cells in human Hutchinson-Gilford progeria syndrome.
    Matrone G; Thandavarayan RA; Walther BK; Meng S; Mojiri A; Cooke JP
    Cell Cycle; 2019 Oct; 18(19):2495-2508. PubMed ID: 31411525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelial progerin expression causes cardiovascular pathology through an impaired mechanoresponse.
    Osmanagic-Myers S; Kiss A; Manakanatas C; Hamza O; Sedlmayer F; Szabo PL; Fischer I; Fichtinger P; Podesser BK; Eriksson M; Foisner R
    J Clin Invest; 2019 Feb; 129(2):531-545. PubMed ID: 30422822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progerin-Induced Replication Stress Facilitates Premature Senescence in Hutchinson-Gilford Progeria Syndrome.
    Wheaton K; Campuzano D; Ma W; Sheinis M; Ho B; Brown GW; Benchimol S
    Mol Cell Biol; 2017 Jul; 37(14):. PubMed ID: 28483909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma Progerin in Patients With Hutchinson-Gilford Progeria Syndrome: Immunoassay Development and Clinical Evaluation.
    Gordon LB; Norris W; Hamren S; Goodson R; LeClair J; Massaro J; Lyass A; D'Agostino RB; Tuminelli K; Kieran MW; Kleinman ME
    Circulation; 2023 Jun; 147(23):1734-1744. PubMed ID: 36919608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear membrane ruptures underlie the vascular pathology in a mouse model of Hutchinson-Gilford progeria syndrome.
    Kim PH; Chen NY; Heizer PJ; Tu Y; Weston TA; Fong JL; Gill NK; Rowat AC; Young SG; Fong LG
    JCI Insight; 2021 Aug; 6(16):. PubMed ID: 34423791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased vascular smooth muscle contractility in Hutchinson-Gilford Progeria Syndrome linked to defective smooth muscle myosin heavy chain expression.
    von Kleeck R; Castagnino P; Roberts E; Talwar S; Ferrari G; Assoian RK
    Sci Rep; 2021 May; 11(1):10625. PubMed ID: 34012019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantification of Farnesylated Progerin in Hutchinson-Gilford Progeria Patient Cells by Mass Spectrometry.
    Camafeita E; Jorge I; Rivera-Torres J; Andrés V; Vázquez J
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin decreases progerin expression and alleviates pathological defects of Hutchinson-Gilford progeria syndrome cells.
    Egesipe AL; Blondel S; Lo Cicero A; Jaskowiak AL; Navarro C; Sandre-Giovannoli A; Levy N; Peschanski M; Nissan X
    NPJ Aging Mech Dis; 2016; 2():16026. PubMed ID: 28721276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progerin, an Aberrant Spliced Form of Lamin A, Is a Potential Therapeutic Target for HGPS.
    Kim BH; Chung YH; Woo TG; Kang SM; Park S; Park BJ
    Cells; 2023 Sep; 12(18):. PubMed ID: 37759521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Presence and distribution of progerin in HGPS cells is ameliorated by drugs that impact on the mevalonate and mTOR pathways.
    Clements CS; Bikkul MU; Ofosu W; Eskiw C; Tree D; Makarov E; Kill IR; Bridger JM
    Biogerontology; 2019 Jun; 20(3):337-358. PubMed ID: 31041622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progerin-expressing endothelial cells are unable to adapt to shear stress.
    Danielsson BE; Peters HC; Bathula K; Spear LM; Noll NA; Dahl KN; Conway DE
    Biophys J; 2022 Feb; 121(4):620-628. PubMed ID: 34999130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.